Abbott Laboratories
ABT
C$180.30
Share price
0.00%
Change (1 day)
28.05%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Net assets
Net assets on the balance sheet as of March 2025 : C$67.30 Billion
According to Abbott Laboratories's latest financial reports the company has C$67.30 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Abbott Laboratories - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $C$68.73 B | 33.47% |
| 2023-12-31 | $C$51.49 B | 2.84% |
| 2022-12-31 | $C$50.07 B | 9.08% |
| 2021-12-31 | $C$45.91 B | 9.1% |
| 2020-12-31 | $C$42.08 B | 2.94% |
| 2019-12-31 | $C$40.88 B | -2.31% |
| 2018-12-31 | $C$41.84 B | 7.04% |
| 2017-12-31 | $C$39.09 B | 40.44% |
| 2016-12-31 | $C$27.84 B | -5.89% |
| 2015-12-31 | $C$29.58 B | 17.81% |
| 2014-12-31 | $C$25.11 B | -6.64% |
| 2013-12-31 | $C$26.89 B | 0.88% |
| 2012-12-31 | $C$26.66 B | 6.87% |
| 2011-12-31 | $C$24.94 B | 9.63% |
| 2010-12-31 | $C$22.75 B | -5.55% |
| 2009-12-31 | $C$24.09 B | 13.11% |
| 2008-12-31 | $C$21.30 B | 20.1% |
| 2007-12-31 | $C$17.73 B | 8.39% |
| 2006-12-31 | $C$16.36 B | -2.5% |
| 2005-12-31 | $C$16.78 B | -2.46% |
| 2004-12-31 | $C$17.20 B | 1.47% |
| 2003-12-31 | $C$16.95 B | 0.68% |
| 2002-12-31 | $C$16.84 B | 16.71% |
| 2001-12-31 | $C$14.43 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | C$107.14 B | 59.20% | 🇺🇸 USA |
 Pfizer PFE | C$124.33 B | 84.73% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | C$67.88 B | 0.86% | 🇺🇸 USA |
 Hologic HOLX | C$6.33 B | -90.59% | 🇺🇸 USA |
 Medtronic MDT | C$66.19 B | -1.65% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | C$23.93 B | -64.44% | 🇺🇸 USA |
 Boston Scientific BSX | C$30.79 B | -54.25% | 🇺🇸 USA |
 AstraZeneca AZN | C$56.42 B | -16.17% | 🇬🇧 UK |
 Novartis NVS | C$52.74 B | -21.63% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | C$24.20 B | -64.04% | 🇬🇧 UK |